Get started
Author

Zoltán Hujber

Observed names: Hujber, Zoltán, Z. Hujber, Zoltan Hujber
ORCID: 0000-0002-9790-8044
Observed ORCID: 0000-0002-9790-8044
OpenAlex ID: A5082703892
Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness
2018 · Edit Mikó, András Vida, et al. · Biochimica et Biophysica Acta (BBA) - Bioenergetics · 213
GABA, glutamine, glutamate oxidation and succinic semialdehyde dehydrogenase expression in human gliomas
2018 · Zoltán Hujber, Gergő Horváth, et al. · Journal of Experimental & Clinical Cancer Research · 41
PDF
Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas
2020 · Balazs Sarkadi, Katalin Meszaros, et al. · Cancers · 26
PDF
Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells
2017 · Zoltán Hujber, Gábor Petővári, et al. · Journal of Experimental & Clinical Cancer Research · 26
PDF
Chlorotoxin binds to both matrix metalloproteinase 2 and neuropilin 1
2023 · Sándor Farkas, Daniel Cioca, et al. · Journal of Biological Chemistry · 23
PDF
The SDHB Arg230His mutation causing familial paraganglioma alters glycolysis in a new Caenorhabditis elegans model
2020 · Éva Saskői, Zoltán Hujber, et al. · Disease Models & Mechanisms · 20
PDF
In situ analysis of mTORC1/2 and cellular metabolism–related proteins in human Lymphangioleiomyomatosis
2018 · Ildiko Krencz, Anna Sebestyen, et al. · Human Pathology · 20
Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells
2019 · Gábor Petővári, Titanilla Dankó, et al. · Pathology & Oncology Research · 19
PDF
Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells
2018 · Gábor Petővári, Zoltán Hujber, et al. · Cancer Cell International · 19
PDF
Coadministration of Cariprazine with a Moderate CYP3A4 Inhibitor in Patients with Schizophrenia: Implications for Dose Adjustment and Safety Monitoring
2024 · Máté Szabó, Zoltán Hujber, et al. · Clinical Pharmacokinetics · 8
PDF
The Effects of Different mTOR Inhibitors in EGFR Inhibitor Resistant Colon Carcinoma Cells
2018 · Tamás Sticz, Anna Molnár, et al. · Pathology & Oncology Research · 8
Inhibition of glutaminases as a potential novel treatment for SDHB-associated pheochromocytomas/paragangliomas
2020 · Balázs Sarkadi, Meszaros Katalin, et al. · Endocrine Abstracts · 6
Characterisation of bioenergetic pathways and related regulators by multiple assays in human tumour cells
2016 · A. Jeney, Z. Hujber, et al. · Cancer Cell International · 5
PDF
Lack of Clinically Meaningful Effect of Cariprazine on the Pharmacokinetics of a Combined Oral Contraceptive
2024 · Márta Erzsébet Rosa, Zoltán Juhász, et al. · Neurology and Therapy · 1
PDF
The Arg244His missense mutation in SDHB-1 leads to altered metabolism in Caenorhabditis elegans: a new disease model
2019 · Eva Saskoi, Zoltan Hujber, et al. · Endocrine Abstracts · 1
Bioenergetic changes in breast cancer cells by lithocholic acid
2018 · Edit Mikó, András Vida, et al. · Biochimica et Biophysica Acta (BBA) - Bioenergetics · 1
PDF
P.0904 Results of a phase 1 trial investigating the effect of cariprazine on the pharmacokinetics of a combined oral contraceptive
2021 · J. Harsanyi, M. Kapás, et al. · European Neuropsychopharmacology
Cellular modelling of SDH-associated pathomechanism of pheochromocytomas and paragangliomas
2019 · Balazs Sarkadi, Katalin Meszaros, et al. · Endocrine Abstracts
Substrate oxidation differences in human glioma cells and their potential clinical significance
2018 · Anna Sebestyén, Zoltán Hujber, et al. · Biochimica et Biophysica Acta (BBA) - Bioenergetics
PDF
PO-253 Characteristics of cellular respiration, glycolytic activity and related metabolic features in wild type and IDH1 mutant glioma cells
2018 · Z. Hujber, G. Horváth, et al. · ESMO Open
PO-484 Immunohistochemical analysis of mTORC1 and mTORC2-related proteins in renal cell carcinoma of kidney transplant recipients
2018 · I. Krencz, G. Végső, et al. · ESMO Open
PO-231 mTOR activity differences and related metabolic activity in human breast cancer cell lines
2018 · G. Petővári, Z. Hujber, et al. · ESMO Open
Additional file 2: Figure S2. of Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells
2017 · Hujber, Zoltán, Petővári, Gábor, et al. · Figshare
Additional file 1: Figure S1. of Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells
2017 · Hujber, Zoltán, Petővári, Gábor, et al. · Figshare
[Measuring 14C-glucose and 14C-acetate oxidation in tumour cells and tumorous host organism].
2015 · Zoltán Hujber, András Jeney, et al. · PubMed
Works count: 35
Citation count: 437
H-index: 9
I10-index: 9
Year
Topic
Type